Doubling up against anthrax

A novel anthrax vaccine protects against both bacilli and released toxins

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Anthrax infections can rapidly progress from nonspecific initial symptoms to death. This is caused by a dual process of bacterial replication and toxin production, but the only human vaccine currently available is directed at only the toxins and does not target bacilli multiplication. In the September 2 PNAS, Gi-Eun Rhie and colleagues at Harvard Medical School describe a dually active anthrax vaccine (DAAV) that confers simultaneous protection against both bacilli and toxins (PNAS, DOI:cgi/doi/10.1073/pnas.1834478100, September 2, 2003).

Rhie et al. created a DAAV vaccine by conjugating the capsular poly-γ-D-glutamic acid (PGA) to protective antigen (PA). This converted the weakly immunogenic PGA to a potent immunogen and synergistically enhanced the humoral response to PA. The authors observed that PGA-specific antibodies bound to encapsulated bacilli and promoted the complement-mediated killing of bacilli. In addition, PA-specific antibodies neutralized toxin activity and protected against lethal challenges with anthrax toxin.

"We envision that our DAAVs ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio